Free Trial

TG Therapeutics (TGTX) News Today

→ No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad)
Free TGTX Stock Alerts
$15.85
+0.04 (+0.25%)
(As of 06/7/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends
June 7 at 7:50 AM | globenewswire.com
TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 5 at 8:33 AM | marketbeat.com
Rafferty Asset Management LLC Reduces Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)
Rafferty Asset Management LLC cut its position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 33.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 571,126 shares of the biopharmaceutical company's stock after selling
June 4, 2024 | marketbeat.com
Norges Bank Makes New $18.36 Million Investment in TG Therapeutics, Inc. (NASDAQ:TGTX)
Norges Bank bought a new position in shares of TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 1,075,037 shares of the biopharmaceutical company's stock,
June 3, 2024 | globenewswire.com
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
June 3, 2024 | marketbeat.com
UBS Group AG Has $9.65 Million Stake in TG Therapeutics, Inc. (NASDAQ:TGTX)
UBS Group AG grew its position in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 67.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 564,836 shares of the biopharmaceutical company's stock after buying an
June 3, 2024 | americanbankingnews.com
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Rating of "Moderate Buy" from Brokerages
June 2, 2024 | marketbeat.com
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Corient Private Wealth LLC
Corient Private Wealth LLC boosted its holdings in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 231.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 93,381 shares of the biopharmaceutical company's stock after acquiring an additional 65
May 31, 2024 | globenewswire.com
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
May 28, 2024 | globenewswire.com
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
May 20, 2024 | marketbeat.com
TG Therapeutics, Inc. (NASDAQ:TGTX) Stock Position Reduced by BNP Paribas Financial Markets
BNP Paribas Financial Markets decreased its stake in TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) by 74.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 293,607 shares of the biopharmac
May 17, 2024 | marketbeat.com
TG Therapeutics (NASDAQ:TGTX) Shares Down 4.1%
TG Therapeutics (NASDAQ:TGTX) Stock Price Down 4.1%
May 3, 2024 | seekingalpha.com
TG Therapeutics: Less Room For Doubt About Briumvi
May 3, 2024 | finance.yahoo.com
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2024 Earnings Call Transcript
May 3, 2024 | marketbeat.com
FY2025 EPS Estimates for TG Therapeutics, Inc. (NASDAQ:TGTX) Decreased by Analyst
TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Equities researchers at B. Riley decreased their FY2025 earnings per share (EPS) estimates for shares of TG Therapeutics in a research note issued to investors on Wednesday, May 1st. B. Riley analyst M. Mamtani now anticipates that the biopharma
May 3, 2024 | fool.com
Why TG Therapeutics Stock Was Rocketing Higher This Week
May 3, 2024 | finance.yahoo.com
Rainbows and Unicorns: TG Therapeutics, Inc. (NASDAQ:TGTX) Analysts Just Became A Lot More Optimistic
May 2, 2024 | markets.businessinsider.com
Sell Rating on TG Therapeutics: Caution Amid Competitive Threats and Decelerating Prescription Growth
May 2, 2024 | marketbeat.com
TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $49.00 at HC Wainwright
HC Wainwright boosted their target price on TG Therapeutics from $45.00 to $49.00 and gave the stock a "buy" rating in a research report on Thursday.
May 2, 2024 | marketbeat.com
TG Therapeutics (NASDAQ:TGTX) Releases Earnings Results, Misses Estimates By $0.02 EPS
TG Therapeutics (NASDAQ:TGTX - Get Free Report) posted its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.02). The firm had revenue of $63.47 million for the quarter, compared to the consensus estimate of $54.60 million. TG Therapeutics had a return on equity of 12.89% and a net margin of 5.42%. The firm's quarterly revenue was up 713.5% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.28) EPS.
May 2, 2024 | finance.yahoo.com
TG Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 2, 2024 | marketbeat.com
Q2 2024 EPS Estimates for TG Therapeutics, Inc. Raised by B. Riley (NASDAQ:TGTX)
TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Research analysts at B. Riley upped their Q2 2024 earnings estimates for shares of TG Therapeutics in a report issued on Tuesday, April 30th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will post earnings per s
May 2, 2024 | gurufocus.com
Q1 2024 TG Therapeutics Inc Earnings Call Transcript
May 1, 2024 | markets.businessinsider.com
Hold Rating on TG Therapeutics Amidst Strong Briumvi Launch and Competitive Market Pressures
May 1, 2024 | marketwatch.com
TG Therapeutics Shares Rise 27% After 1Q Revenue Beat
May 1, 2024 | markets.businessinsider.com
TG Therapeutics Inc. Q1 Loss decreases, but misses estimates
May 1, 2024 | msn.com
TG Therapeutics jumps as Q1 Briumvi sales top guidance
May 1, 2024 | finance.yahoo.com
TG Therapeutics Inc (TGTX) Surpasses Revenue Estimates in Q1 2024, Despite Widening Net Loss
May 1, 2024 | marketbeat.com
TG Therapeutics Target of Unusually Large Options Trading (NASDAQ:TGTX)
TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Traders acquired 13,983 call options on the company. This is an increase of 88% compared to the average daily volume of 7,433 call options.
May 1, 2024 | investorplace.com
TGTX Stock Earnings: TG Therapeutics Misses EPS, Beats Revenue for Q1 2024
May 1, 2024 | marketbeat.com
TG Therapeutics, Inc. (NASDAQ:TGTX) Forecasted to Post FY2026 Earnings of $1.60 Per Share
TG Therapeutics, Inc. (NASDAQ:TGTX - Free Report) - Research analysts at B. Riley cut their FY2026 earnings estimates for shares of TG Therapeutics in a note issued to investors on Tuesday, April 30th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will post earnin
May 1, 2024 | globenewswire.com
TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
April 30, 2024 | globenewswire.com
TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update
April 23, 2024 | markets.businessinsider.com
Bank of America Securities Keeps Their Sell Rating on TG Therapeutics (TGTX)
April 18, 2024 | marketbeat.com
TG Therapeutics (NASDAQ:TGTX) Stock Price Up 4.8%
TG Therapeutics (NASDAQ:TGTX) Stock Price Up 4.8%
April 18, 2024 | marketbeat.com
TG Therapeutics (NASDAQ:TGTX) Earns "Overweight" Rating from JPMorgan Chase & Co.
JPMorgan Chase & Co. reiterated an "overweight" rating and issued a $25.00 price target on shares of TG Therapeutics in a research note on Thursday.
April 18, 2024 | globenewswire.com
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
April 18, 2024 | globenewswire.com
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis
April 17, 2024 | seekingalpha.com
TG Therapeutics: The Cloud Over Briumvi
April 15, 2024 | msn.com
TG Posts Gains on Results of MS Drug Test
April 15, 2024 | globenewswire.com
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
April 15, 2024 | globenewswire.com
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
April 14, 2024 | nasdaq.com
TG Therapeutics Breaks Below 200-Day Moving Average - Notable for TGTX
April 14, 2024 | marketbeat.com
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Recommendation of "Moderate Buy" from Brokerages
TG Therapeutics, Inc. (NASDAQ:TGTX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the six brokerages that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating and five have issued a buy rating on the compan
April 12, 2024 | seekingalpha.com
TG Therapeutics: BRIUMVI Development Could Lead To Great Results
March 19, 2024 | finance.yahoo.com
Is TG Therapeutics, Inc.'s (NASDAQ:TGTX) Recent Price Movement Underpinned By Its Weak Fundamentals?
March 17, 2024 | investing.com
Tg therapeutics director sells shares worth over $79k
March 16, 2024 | finance.yahoo.com
TGTX Mar 2024 20.500 call
March 16, 2024 | finance.yahoo.com
TGTX Mar 2024 16.500 put
March 16, 2024 | finance.yahoo.com
TGTX Apr 2024 19.500 call
March 16, 2024 | finance.yahoo.com
TGTX Apr 2024 11.000 put
Get TG Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter.

We’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How) (Ad)

Bitcoin can and probably will hit the $1 MILLION level this decade. That’s more than 1,000% upside from these levels.

But there are at least 10 different coins that I like even better.

TGTX Media Mentions By Week

TGTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TGTX
News Sentiment
▼
1.02

0.73
▲
Average
Medical
News Sentiment

TGTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TGTX Articles
This Week
▼
7

4
▲
TGTX Articles
Average Week

Get TG Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:TGTX) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners
Millionaire-Making “Wealth Pattern” Just Repeated on April 22
If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.
Paradigm Press | Sponsored
Breaking - The US Gov. Seized CITGO
Do you want an investment that can double or triple your money in the next three months? The US Court is cu...
Augury Research | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
AI Hell Will Break Loose [June 30, 2024] …
On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...
Banyan Hill Publishing | Sponsored
Was the Great Financial Crisis fun?
The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...
Brooks Enterprises | Sponsored
Shocking $16T Elon Musk Crypto Leak
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...
Crypto 101 Media | Sponsored